Y Intercept (Hong Kong) LTD Adma Biologics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 74,891 shares of ADMA stock, worth $1.42 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
74,891
Previous 36,082
107.56%
Holding current value
$1.42 Million
Previous $715,000
90.63%
% of portfolio
0.04%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding ADMA
# of Institutions
390Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$354 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$319 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$244 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$217 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$107 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.72B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...